Benzinga | Nov 22, 2021 10:31AM EST

Spruce Biosciences Sponsored Study Titled 'A Phase 2 Study to Evaluate the Safety, PK, and Exploratory PD of Tildacerfont in Children With CAH' Posted To ClinicalTrials.gov; Study Not Yet Recruiting

https://clinicaltrials.gov/ct2/show/NCT05128942